Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001493152-24-034310
Filing Date
2024-08-29
Accepted
2024-08-29 09:28:50
Documents
7
Effectiveness Date
2024-08-29

Document Format Files

Seq Description Document Type Size
1 forms-8.htm S-8 87430
2 ex5-1.htm EX-5.1 11062
3 ex23-1.htm EX-23.1 2588
4 ex99-1.htm EX-99.1 96326
5 CALCULATION OF REGISTRATION FEE ex107-1.htm EX-FILING FEES 22201
6 ex5-1_001.jpg GRAPHIC 263080
7 ex5-1_002.jpg GRAPHIC 196050
  Complete submission text file 0001493152-24-034310.txt   824742
Mailing Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648
Business Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648 (609) 896-9100
Imunon, Inc. (Filer) CIK: 0000749647 (see all company filings)

EIN.: 521256615 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-281833 | Film No.: 241259280
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)